e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Late-Breaking Abstracts Session: New treatments and targets for airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: Inhaled calcium salts reduce tobacco smoke induced airway inflammation and improve lung pathology
J. Kenyon, P. Woodman, D. Spicer, P. Wright, V. Russell, R. Clarke, D. Hava (Lexington, United States Of America; Slough, United Kingdom)
Source:
Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session:
Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session type:
Oral Presentation
Number:
4499
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kenyon, P. Woodman, D. Spicer, P. Wright, V. Russell, R. Clarke, D. Hava (Lexington, United States Of America; Slough, United Kingdom). Late-breaking abstract: Inhaled calcium salts reduce tobacco smoke induced airway inflammation and improve lung pathology. Eur Respir J 2011; 38: Suppl. 55, 4499
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Inhaled calcium salts reduce expression of inflammatory mediators associated with tobacco smoke exposure to reduce airway inflammation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Late-breaking abstract: Inhaled calcium based dry powder inhibits rhinovirus-induced inflammation and exacerbation in a mouse model of allergic airway inflammation
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Effect of iron deficiency on airway inflammation and pulmonary function in mice exposed to cigarette smoke
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017
LSC Abstract – Cigarette smoke exposure accelerates airway mucus accumulation and inflammation in ENaC-overexpressed mice
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Impact of cigarette smoke exposure on host–bacterial pathogen interactions
Source: Eur Respir J 2012; 39: 467-477
Year: 2012
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Comparative airway response to high- versus low-molecular weight agents in occupational asthma
Source: Eur Respir J 2009; 33: 734-739
Year: 2009
Tiotropium inhibits pulmonary inflammation in a subchronic cigarette smoke mouse model of COPD
Source: Annual Congress 2010 - Bronchodilators in airways disease
Year: 2010
Repeated exposure to organic material alters inflammatory and physiological airway responses
Source: Eur Respir J 2009; 34: 80-88
Year: 2009
Acute cigarette smoke exposure in mice promotes airway inflammation consistent with the hallmarks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 80s
Year: 2003
Eucalyptol reduced inflammation and oxidative stress on mouse lungs exposed to long and short-term cigarette smoke
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Late-breaking abstract: Repeated bronchoconstriction without additional inflammation is sufficient to induce airway remodelling in asthma
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Tiotropium reduces established pulmonary inflammation in a 12 weeks cigarette smoke mouse model of COPD
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011
Alveolar changes in a chronic tobacco smoke inhalation COPD mouse model
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
Role of oxidants during lung development and bronchial hyper-reactivity after in utero nicotine exposure
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Acute effect of passive cigarette smoking on airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept